BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23180992)

  • 1. Adherence to clinical practice guidelines for adjuvant chemotherapy for colorectal cancer in a Canadian province: a population-based analysis.
    Rayson D; Urquhart R; Cox M; Grunfeld E; Porter G
    J Oncol Pract; 2012 Jul; 8(4):253-9. PubMed ID: 23180992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based longitudinal study of follow-up care for patients with colorectal cancer in Nova Scotia.
    Urquhart R; Folkes A; Porter G; Kendell C; Cox M; Dewar R; Grunfeld E
    J Oncol Pract; 2012 Jul; 8(4):246-52. PubMed ID: 23180991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of treatment received versus long-standing guidelines for stage III colon and stage II/III rectal cancer patients diagnosed in Alberta, Saskatchewan, and Manitoba in 2004.
    Cree M; Tonita J; Turner D; Nugent Z; Alvi R; Barss R; King C; Winget M
    Clin Colorectal Cancer; 2009 Jul; 8(3):141-5. PubMed ID: 19632928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily practice in guideline adherence to adjuvant chemotherapy in stage III colon cancer and predictors of outcome.
    van den Berg I; van de Weerd S; van Klaveren D; Coebergh van den Braak RRJ; van Krieken JHJM; Koopman M; Roodhart JML; Medema JP; IJzermans JNM
    Eur J Surg Oncol; 2021 Aug; 47(8):2060-2068. PubMed ID: 33745794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancer.
    Lindskog EB; Gunnarsdóttir KÁ; Derwinger K; Wettergren Y; Glimelius B; Kodeda K
    BMC Cancer; 2014 Dec; 14():948. PubMed ID: 25495897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Underutilization or appropriate care? Assessing adjuvant chemotherapy use and survival in 3 heterogenous subpopulations with stage II/III colorectal cancer within a large integrated health system.
    Chen Y; Shankaran V; Hahn EE; Haupt EC; Bansal A
    J Manag Care Spec Pharm; 2023 Jun; 29(6):635-646. PubMed ID: 37276035
    [No Abstract]   [Full Text] [Related]  

  • 7. Adherence to treatment guidelines in stage II/III rectal cancer in Alberta, Canada.
    Eldin NS; Yasui Y; Scarfe A; Winget M
    Clin Oncol (R Coll Radiol); 2012 Feb; 24(1):e9-17. PubMed ID: 21802914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adjuvant and palliative chemotherapy of colorectal cancer in Germany outside controlled trials].
    Lamberti C; Lundin S; Bogdanow M; Gorschlüter M; Schmidt-Wolf IG; Sauerbruch T
    Dtsch Med Wochenschr; 2006 Mar; 131(10):485-90. PubMed ID: 16511737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to treatment guidelines and survival for older patients with stage II or III colon cancer in Texas from 2001 through 2011.
    Zhao H; Zhang N; Ho V; Ding M; He W; Niu J; Yang M; Du XL; Zorzi D; Chavez-MacGregor M; Giordano SH
    Cancer; 2018 Feb; 124(4):679-687. PubMed ID: 29140558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality measures for the use of adjuvant chemotherapy and radiation therapy in patients with colorectal cancer: a systematic review.
    Prosnitz RG; Patwardhan MB; Samsa GP; Mantyh CR; Fisher DA; McCrory DC; Cline KE; Gray RN; Morse MA
    Cancer; 2006 Nov; 107(10):2352-60. PubMed ID: 17039499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inequity in access to guideline-recommended colorectal cancer treatment in Nova Scotia, Canada.
    Maddison AR; Asada Y; Urquhart R; Johnston G; Burge F; Porter G
    Healthc Policy; 2012 Nov; 8(2):71-87. PubMed ID: 23968617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality indicators for colorectal cancer surgery and care according to patient-, tumor-, and hospital-related factors.
    Mathoulin-Pélissier S; Bécouarn Y; Belleannée G; Pinon E; Jaffré A; Coureau G; Auby D; Renaud-Salis JL; Rullier E;
    BMC Cancer; 2012 Jul; 12():297. PubMed ID: 22813349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concordance with clinical practice guidelines for adjuvant chemotherapy in patients with stage I-III colon cancer: experience in 2 Canadian provinces.
    Wirtzfeld DA; Mikula L; Gryfe R; Ravani P; Dicks EL; Parfrey P; Gallinger S; Pollett WG
    Can J Surg; 2009 Apr; 52(2):92-7. PubMed ID: 19399202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network analysis.
    Khrizman P; Niland JC; ter Veer A; Milne D; Bullard Dunn K; Carson WE; Engstrom PF; Shibata S; Skibber JM; Weiser MR; Schrag D; Benson AB
    J Clin Oncol; 2013 Jan; 31(1):30-8. PubMed ID: 23169502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of guideline-recommended adjuvant therapies and survival outcomes for people with colorectal cancer at tertiary referral hospitals in South Australia.
    Adelson P; Fusco K; Karapetis C; Wattchow D; Joshi R; Price T; Sharplin G; Roder D
    J Eval Clin Pract; 2018 Feb; 24(1):135-144. PubMed ID: 28474459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timely access and quality of care in colorectal cancer: a population-based cohort study using administrative data.
    Porter G; Urquhart R; Kendell C; Bu J; McConnell Y; Grunfeld E
    BMC Res Notes; 2013 Sep; 6():355. PubMed ID: 24010527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diminishing differences in treatment between patients with colorectal cancer with and without diabetes: a population-based study.
    Zanders MM; van Steenbergen LN; Haak HR; Rutten HJ; Pruijt JF; Poortmans PM; Lemmens VE; van de Poll-Franse LV
    Diabet Med; 2013 Oct; 30(10):1181-8. PubMed ID: 23758334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor compliance with adjuvant chemotherapy use associated with poorer survival in patients with rectal cancer: An NCDB analysis.
    Xu Z; Mohile SG; Tejani MA; Becerra AZ; Probst CP; Aquina CT; Hensley BJ; Arsalanizadeh R; Noyes K; Monson JR; Fleming FJ
    Cancer; 2017 Jan; 123(1):52-61. PubMed ID: 27560162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of patients with stage III colon adenocarcinoma who fail to receive guideline-recommended treatment.
    Winget M; Hossain S; Yasui Y; Scarfe A
    Cancer; 2010 Oct; 116(20):4849-56. PubMed ID: 20578180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of care for European colorectal cancer patients diagnosed 1996-1998: a EUROCARE high resolution study.
    Gatta G; Zigon G; Aareleid T; Ardanaz E; Bielska-Lasota M; Galceran J; Góźdź S; Hakulinen T; Martinez-Garcia C; Plesko I; Zakelj MP; Rachtan J; Tagliabue G; Vercelli M; Faivre J
    Acta Oncol; 2010 Aug; 49(6):776-83. PubMed ID: 20429733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.